Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis

Intra-articular Hyaluronic Acid: Potential Treatment of Younger Patients with Knee Injury and/or Post-Traumatic Arthritis

(2011) Laith M. Jazrawi et al.   PHYSICIAN AND SPORTSMEDICINE

Activin A Binds to Perlecan through Its Pro-region That Has Heparin/Heparan Sulfate Binding Activity

(2010) Shaoliang Li et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Recommendations for the use of preclinical models in the study and treatment of osteoarthritis

(2010) R. Poole et al.   OSTEOARTHRITIS AND CARTILAGE

Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial

(2009) X Chevalier et al.   ANNALS OF THE RHEUMATIC DISEASES

Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release

(2009) Amit K. Jha et al.   BIOMATERIALS

Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans

(2009) Catherine Kirn-Safran et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Diverse Cell Signaling Events Modulated by Perlecan†

(2008) John M. Whitelock et al.   BIOCHEMISTRY

Modulation of xylosyltransferase I expression provides a mechanism regulating glycosaminoglycan chain synthesis during cartilage destruction and repair

(2008) Narayanan Venkatesan et al.   FASEB JOURNAL

The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study

(2008) G. Tardif et al.   OSTEOARTHRITIS AND CARTILAGE

Early Tissue Patterning Recreated by Mouse Embryonic Fibroblasts in a Three-Dimensional Environment

(2008) Lluís Quintana et al.   TISSUE ENGINEERING PART A